Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: E9AE28
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 211 | 215 | PF00656 | 0.535 |
CLV_C14_Caspase3-7 | 225 | 229 | PF00656 | 0.381 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.372 |
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.531 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.365 |
CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.371 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.585 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.377 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.335 |
DEG_APCC_DBOX_1 | 186 | 194 | PF00400 | 0.330 |
DOC_MAPK_gen_1 | 186 | 193 | PF00069 | 0.351 |
DOC_MAPK_gen_1 | 48 | 56 | PF00069 | 0.484 |
DOC_MAPK_MEF2A_6 | 186 | 195 | PF00069 | 0.330 |
DOC_MAPK_MEF2A_6 | 48 | 56 | PF00069 | 0.500 |
DOC_MAPK_NFAT4_5 | 49 | 57 | PF00069 | 0.436 |
DOC_MIT_MIM_1 | 30 | 38 | PF04212 | 0.334 |
LIG_APCC_ABBA_1 | 109 | 114 | PF00400 | 0.556 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.602 |
LIG_deltaCOP1_diTrp_1 | 252 | 260 | PF00928 | 0.391 |
LIG_EVH1_2 | 146 | 150 | PF00568 | 0.576 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.468 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.526 |
LIG_FHA_2 | 244 | 250 | PF00498 | 0.435 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.493 |
LIG_LIR_Gen_1 | 115 | 126 | PF02991 | 0.403 |
LIG_LIR_Gen_1 | 204 | 212 | PF02991 | 0.429 |
LIG_LIR_Gen_1 | 232 | 242 | PF02991 | 0.383 |
LIG_LIR_Gen_1 | 80 | 90 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 115 | 121 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 204 | 209 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 232 | 237 | PF02991 | 0.375 |
LIG_LIR_Nem_3 | 252 | 256 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 55 | 61 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 80 | 85 | PF02991 | 0.481 |
LIG_NRBOX | 189 | 195 | PF00104 | 0.409 |
LIG_Pex14_1 | 234 | 238 | PF04695 | 0.445 |
LIG_Pex14_4 | 78 | 83 | PF04695 | 0.405 |
LIG_SH2_NCK_1 | 265 | 269 | PF00017 | 0.477 |
LIG_SH2_NCK_1 | 72 | 76 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.468 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.518 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.604 |
LIG_SH3_3 | 165 | 171 | PF00018 | 0.685 |
LIG_SUMO_SIM_par_1 | 192 | 197 | PF11976 | 0.319 |
LIG_TRAF2_1 | 246 | 249 | PF00917 | 0.529 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.668 |
MOD_CK1_1 | 213 | 219 | PF00069 | 0.611 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.417 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.613 |
MOD_CK2_1 | 218 | 224 | PF00069 | 0.539 |
MOD_CK2_1 | 243 | 249 | PF00069 | 0.438 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.493 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.484 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.586 |
MOD_GlcNHglycan | 120 | 124 | PF01048 | 0.493 |
MOD_GlcNHglycan | 174 | 177 | PF01048 | 0.601 |
MOD_GlcNHglycan | 181 | 184 | PF01048 | 0.395 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.673 |
MOD_GSK3_1 | 154 | 161 | PF00069 | 0.681 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.764 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.547 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.334 |
MOD_NEK2_1 | 261 | 266 | PF00069 | 0.495 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.457 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.392 |
MOD_PIKK_1 | 22 | 28 | PF00454 | 0.521 |
MOD_PK_1 | 208 | 214 | PF00069 | 0.431 |
MOD_PKA_2 | 150 | 156 | PF00069 | 0.654 |
MOD_PKA_2 | 158 | 164 | PF00069 | 0.645 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.459 |
MOD_Plk_4 | 229 | 235 | PF00069 | 0.392 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.537 |
MOD_SUMO_rev_2 | 248 | 256 | PF00179 | 0.418 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.406 |
TRG_ENDOCYTIC_2 | 206 | 209 | PF00928 | 0.468 |
TRG_ER_diArg_1 | 33 | 35 | PF00400 | 0.533 |
TRG_NES_CRM1_1 | 188 | 204 | PF08389 | 0.463 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IMM1 | Leptomonas seymouri | 55% | 100% |
A0A0S4ING2 | Bodo saltans | 25% | 100% |
A0A1X0NZY4 | Trypanosomatidae | 33% | 100% |
A0A3Q8IIV0 | Leishmania donovani | 94% | 100% |
A0A3R7KCM5 | Trypanosoma rangeli | 37% | 100% |
A4HHI0 | Leishmania braziliensis | 73% | 100% |
A4I4K6 | Leishmania infantum | 94% | 100% |
C9ZLB6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
E9ALQ5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
V5B997 | Trypanosoma cruzi | 35% | 100% |